USD
$0.00
(0.00%
)At Close (As of Sep 12, 2025)
$3.15M
Market Cap
-
P/E Ratio
-9.97
EPS
$8.32
52 Week High
$0.85
52 Week Low
HEALTHCARE
Sector
Field | Value (USD) |
---|---|
Gross Profit | -$337K |
Total Revenue | $0 |
Cost Of Revenue | $337K |
Costof Goods And Services Sold | $337K |
Operating Income | -$9.6M |
Selling General And Administrative | $6.5M |
Research And Development | $2.8M |
Operating Expenses | $9.3M |
Investment Income Net | - |
Net Interest Income | $219 |
Interest Income | $219 |
Interest Expense | - |
Non Interest Income | - |
Other Non Operating Income | - |
Depreciation | - |
Depreciation And Amortization | $337K |
Income Before Tax | -$9.6M |
Income Tax Expense | $8.9K |
Interest And Debt Expense | - |
Net Income From Continuing Operations | -$9.6M |
Comprehensive Income Net Of Tax | - |
Ebit | -$9.6M |
Ebitda | -$9.2M |
Net Income | -$9.6M |
Field | Value (USD) |
---|---|
Total Assets | $3.1M |
Total Current Assets | $2.7M |
Cash And Cash Equivalents At Carrying Value | $2.2M |
Cash And Short Term Investments | $2.2M |
Inventory | - |
Current Net Receivables | - |
Total Non Current Assets | $348K |
Property Plant Equipment | - |
Accumulated Depreciation Amortization Ppe | - |
Intangible Assets | $42K |
Intangible Assets Excluding Goodwill | $42K |
Goodwill | - |
Investments | - |
Long Term Investments | - |
Short Term Investments | - |
Other Current Assets | $494K |
Other Non Current Assets | - |
Total Liabilities | $1.5M |
Total Current Liabilities | $1.5M |
Current Accounts Payable | $522K |
Deferred Revenue | - |
Current Debt | - |
Short Term Debt | - |
Total Non Current Liabilities | $0 |
Capital Lease Obligations | - |
Long Term Debt | - |
Current Long Term Debt | - |
Long Term Debt Noncurrent | - |
Short Long Term Debt Total | - |
Other Current Liabilities | $707K |
Other Non Current Liabilities | - |
Total Shareholder Equity | $1.6M |
Treasury Stock | - |
Retained Earnings | -$106M |
Common Stock | $6.8K |
Common Stock Shares Outstanding | $503K |
Field | Value (USD) |
---|---|
Operating Cashflow | -$7.7M |
Payments For Operating Activities | - |
Proceeds From Operating Activities | - |
Change In Operating Liabilities | - |
Change In Operating Assets | - |
Depreciation Depletion And Amortization | $337K |
Capital Expenditures | $0 |
Change In Receivables | - |
Change In Inventory | - |
Profit Loss | - |
Cashflow From Investment | - |
Cashflow From Financing | $7.7M |
Proceeds From Repayments Of Short Term Debt | - |
Payments For Repurchase Of Common Stock | - |
Payments For Repurchase Of Equity | - |
Payments For Repurchase Of Preferred Stock | - |
Dividend Payout | - |
Dividend Payout Common Stock | - |
Dividend Payout Preferred Stock | - |
Proceeds From Issuance Of Common Stock | - |
Proceeds From Issuance Of Long Term Debt And Capital Securities Net | - |
Proceeds From Issuance Of Preferred Stock | - |
Proceeds From Repurchase Of Equity | $1.1M |
Proceeds From Sale Of Treasury Stock | - |
Change In Cash And Cash Equivalents | - |
Change In Exchange Rate | - |
Net Income | -$9.6M |
Field | Value (USD) |
---|---|
Gross Profit | -$337K |
Total Revenue | $0 |
Cost Of Revenue | $337K |
Costof Goods And Services Sold | $337K |
Operating Income | -$9.6M |
Selling General And Administrative | $6.5M |
Research And Development | $2.8M |
Operating Expenses | $9.3M |
Investment Income Net | - |
Net Interest Income | $219 |
Interest Income | $219 |
Interest Expense | - |
Non Interest Income | - |
Other Non Operating Income | - |
Depreciation | - |
Depreciation And Amortization | $337K |
Income Before Tax | -$9.6M |
Income Tax Expense | $8.9K |
Interest And Debt Expense | - |
Net Income From Continuing Operations | -$9.6M |
Comprehensive Income Net Of Tax | - |
Ebit | -$9.6M |
Ebitda | -$9.2M |
Net Income | -$9.6M |
Sector: HEALTHCARE
Industry: BIOTECHNOLOGY
Enveric Biosciences, Inc., a pharmaceutical company, is dedicated to developing various cannabinoid drugs for the treatment of cancer. The company is headquartered in Naples, Florida.